| Bioactivity | Lixudebart is a humanized immunoglobulin G1-kappa, anti-CLDN1 monoclonal antibody[1]. |
| Target | CLDN1 |
| Name | Lixudebart |
| CAS | 2749515-10-2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022. |